| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/21/2011 | CN102197045A Recombinant fragments and synthetic peptides of 17-kDa polypeptide useful in detecting bartonella henselae |
| 09/21/2011 | CN102190712A Polymyxin E composition and preparation method and application thereof |
| 09/21/2011 | CN102190711A Polymyxin E composition and preparation method and application thereof |
| 09/21/2011 | CN102190710A Polymyxin E2 composition, and preparation method and application thereof |
| 09/21/2011 | CN102190709A Synthesis method of luteinizing hormone releasing hormone derivatives |
| 09/21/2011 | CN102190708A Barrel-shaped alpha conantokin Bt1.3 and application thereof |
| 09/21/2011 | CN102190707A Dendritic cell (DC)-based hepatitis B virus T epitope peptide |
| 09/21/2011 | CN102188691A Application of tachyplesin in preparing antihrombotic medicines and health-care products and preparation method thereof |
| 09/21/2011 | CN102188380A Double-target tumor nanoliposome and preparation method thereof |
| 09/20/2011 | US8022180 Method for preventing and treating Alzheimer's disease |
| 09/20/2011 | US8022172 Clostridial toxin substrate comprising fluorphore, lanthanide donor complex and botulin toxin recognition sequence for use in detecting clostridial protease activity |
| 09/20/2011 | US8022033 Echinocandin/carbohydrate complexes |
| 09/20/2011 | US8021664 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 09/15/2011 | WO2011111392A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | WO2011046309A3 A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224279 Anticancer agent |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224152 Synthetic arginine substituted peptides and their use |
| 09/15/2011 | US20110224139 Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 09/15/2011 | US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases |
| 09/15/2011 | US20110224129 Lipopeptide Compounds and Their Use |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110223202 Cationic core-shell peptide nonoparticles |
| 09/15/2011 | US20110223177 Treatment of fibrotic eye disorders |
| 09/15/2011 | US20110223142 Methods and compositions for soft tissue repair |
| 09/15/2011 | US20110219858 Composition for use as a peptide retention standard and a method of predicting peptide hydrophobicity in liquid chromatography |
| 09/15/2011 | CA2792910A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | CA2792674A1 Peptide compounds that can be used as antibacterial agents |
| 09/14/2011 | EP2364734A1 Multi-component biological transport systems |
| 09/14/2011 | EP2364320A1 Degradable supports for tide synthesis |
| 09/14/2011 | EP2125873B1 Tau peptide mimetic for use in treating neurodegenerative disorders |
| 09/14/2011 | EP2007794B1 Lysobactin amides |
| 09/14/2011 | EP1469869B1 Peptide useful in immunomodulation |
| 09/14/2011 | CN102180950A Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 09/14/2011 | CN102180949A Polypeptide capable of specifically combining vessel endothelial growth factor and application thereof |
| 09/14/2011 | CN102180948A Short peptide having kidney protection function as well as preparation method and application thereof |
| 09/14/2011 | CN102180947A A beta aggregation inhibitor |
| 09/14/2011 | CN102178926A Peptide for preventing or treating liver damage |
| 09/14/2011 | CN101817877B Active fragment of anti-opioid peptide |
| 09/14/2011 | CN101519435B Cyclic nonapeptide compound in Hsisha sponge and application thereof |
| 09/14/2011 | CN101514225B Self-polymerization polypeptide and preparation method and application thereof |
| 09/14/2011 | CN101508993B Bullfrog lectin gene, encoded lectin and uses thereof |
| 09/14/2011 | CN101407538B Solid phase synthesis method of ZP120 |
| 09/14/2011 | CN101284870B Polypeptides of anti-measles virus and human immunodeficiency virus and use |
| 09/14/2011 | CN101265292B Polypeptides substances, preparing method and use thereof |
| 09/14/2011 | CN101111510B On-resin peptide cyclization |
| 09/13/2011 | US8017729 Nanographite structure/metal nanoparticle composite |
| 09/13/2011 | US8017728 Metal-binding compounds and uses therefor |
| 09/13/2011 | US8017727 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017585 CXCR4 antagonist and use thereof |
| 09/13/2011 | US8017584 Tumor associated antigens; fusion proteins; antibodies; keyhole limpet hemocyanin carrier enhances immunogenicity |
| 09/13/2011 | US8017579 Treatment of viral infections |
| 09/13/2011 | US8017578 Formulations of Activity Dependent Neurotrophic Factor (ADNF) polypeptide; use reducing neuronal cell death, oxidative stress, and fetal alcohol syndrome associated conditions |
| 09/13/2011 | US8017572 Immune-modulating peptide |
| 09/13/2011 | US8017571 Peptides derived from human BPLP protein |
| 09/13/2011 | US8017131 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 09/09/2011 | WO2011108008A2 Antibody for targeted induction of apoptosis, cdc and adcc mediated killing of cancer cells, tbl-cln1 |
| 09/08/2011 | US20110218379 Epitopes derived from satb2 and uses thereof |
| 09/08/2011 | US20110218152 Compounds for stimulating p-glycoprotein function and uses thereof |
| 09/08/2011 | US20110218145 Antibodies to modified human igf-1/e peptides |
| 09/08/2011 | US20110218142 Inhibitors of Dipeptidylpeptidase IV |
| 09/08/2011 | US20110217790 Novel CD3 Epsilon Immunogens And Antibodies |
| 09/08/2011 | US20110217375 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 09/08/2011 | US20110217326 Method for diagnosing and/or treating tumor |
| 09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 09/08/2011 | US20110217307 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies |
| 09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |
| 09/07/2011 | EP2363710A1 Isolation and identification of T cells |
| 09/07/2011 | EP2363468A1 Tumor antigen peptide and use thereof |
| 09/07/2011 | EP2363424A1 Block copolymers for multifunctional self-assembled systems |
| 09/07/2011 | EP2363413A1 Methods and compositions for the inhibition of modulation of T cell costimulatory pathway by a pathogenic agent |
| 09/07/2011 | EP2363405A1 Anti-infarction molecules |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2362878A2 Apj receptor compounds |
| 09/07/2011 | EP2362782A1 A vaccinia virus protein a46 peptide and use thereof |
| 09/07/2011 | CN1887902B Amino acid short peptide chelate and its prepn |
| 09/07/2011 | CN102177174A Peptides for targeting apoptotic cells and uses thereof |
| 09/07/2011 | CN102174546A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 09/07/2011 | CN102174534A S. pneumoniae antigens |
| 09/07/2011 | CN102174102A Stable analogs of peptide and polypeptide therapeutics |
| 09/07/2011 | CN102174084A Cyclic peptide analogues with thymosin alpha1 activity fragments and polyethylene glycol derivatives thereof |
| 09/07/2011 | CN102174083A Compositae cyclopeptide, immunosuppressive medicine using compositae cyclopeptide as active ingredient and preparation method and application of compositae cyclopeptide |
| 09/07/2011 | CN102174082A Method for preparing exenatide |
| 09/07/2011 | CN102174081A Method for preparing eptifibatide and precursor thereof |
| 09/07/2011 | CN102174080A Polypeptide with brain targeted medicine delivery characteristic and preparation method thereof |
| 09/07/2011 | CN102174079A New assays for preimplantation factor and preimplantation factor peptides |
| 09/07/2011 | CN102174078A Application of tumor cell membrane selectively penetrating peptide |
| 09/07/2011 | CN102174077A Oligopeptide molecules with intramolecular disulfide bonds and application thereof to assisting in protein oxidation renaturation |
| 09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
| 09/07/2011 | CN101638430B Anti-tuberculosis CTL epitope peptide |
| 09/07/2011 | CN101469016B Trichosanthin protein derived peptide and use thereof |
| 09/07/2011 | CN101139383B C end modification endomorphin 2 |
| 09/06/2011 | US8013117 Solution-phase synthesis of leuprolide and its intermediates |
| 09/06/2011 | US8013115 Use of stabilised synthetic compounds in immunoassay |
| 09/06/2011 | US8013113 FRET protease assays for clostridial toxins |